Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Can Kraft Heinz Stock Thrill Investors?

By Chris Markoch, InvestorPlace Contributor

Kraft Heinz stock is down 70% in the last three years. The company is desperately in need of some exciting news and may have found some.

Is Aphria Stock a Victim of Its Own Success?

By Chris Markoch, InvestorPlace Contributor

Aphria stock was the darling of the cannabis sector in 2019 for the underlying company delivering profits. Now, that success is turning into a sentiment headwind.

The Reward Is Not Worth the Risk for Acasti Pharma Stock

By Chris Markoch, InvestorPlace Contributor

Acasti Pharma stock collapsed following an unsuccessful Phase 3 clinical trial. But even this major setback isn't the only headwind impacting shares.

3 Epic Video Game Stocks to Buy Now

By Chris Markoch, InvestorPlace Contributor

Video game stocks are notoriously cyclical. However, 2020 looks like a year for investors to profit. These three stocks may lead the way.

What if Qualcomm Stock Is Priced About Right?

By Chris Markoch, InvestorPlace Contributor

Qualcomm stock enjoyed a stellar performance in 2019. But before diving in, it's wise to consider its present viability, especially with headwinds like the coronavirus at play.

Aurora Stock Needs the Clock to Stop

By Chris Markoch, InvestorPlace Contributor

With enough time, Aurora could move higher on management's recovery initiative. However, time is a luxury that the underlying company does not have.

It’s Time for You to Breakup with Nio Stock

By Chris Markoch, InvestorPlace Contributor

The coronavirus isn’t doing any favors for Nio stock but make no mistake about it: the outbreak is not the fundamental reason it’s failing.

Positive Earnings Look as If They’re Already Priced in to Teva Stock

By Chris Markoch, InvestorPlace Contributor

Teva stock rose 9% after a positive earnings report. But after $3 billion in cost-cutting, investors may be looking for additional revenue.

3 Payments Stocks to Buy Now

By Chris Markoch, InvestorPlace Contributor

Payments stocks will be one of the hottest sectors in 2020. These three companies stand out for taking the technology beyond e-commerce.

Trading Amazon Stock Should Be About Conviction, Not Emotion

By Chris Markoch, InvestorPlace Contributor

With Amazon stock jumping to seemingly ridiculous levels, you’ve got to have complete conviction to invest in shares now.

Load More